sermorelin with retatrutide One month on Reta and

However, little attention has been placed on the effects of semaglutide or other GLP1R agonizts on cannabis consumption even though the prevalence of cannabis use is even higher than that of tobacco use among certain demographics

Phuong, Darline Garibay, Reilly Coch, Kyle W

The Journey Begins: Initial Effects and Early Signs When starting a GLP-1 medication therapy journey, patients can expect to notice initial effects and early signs of the medications impact on their weight and metabolic health within the first few weeks of treatment

Robust clinical evidence supports significant weight loss and cardiometabolic benefits for eligible patients

Setting realistic expectations before starting treatment prevents disappointment later Financial planning for long term costs reduces stress about sustainability Building lifestyle habits during active treatment when appetite suppression helps makes transition to maintenance smoother Having predetermined action thresholds prevents small weight gains from becoming large ones Viewing treatment as health management rather than temporary fix improves psychological relationship with medication Connecting with others using similar medications provides practical support and realistic perspective The common thread among successful long term users is realistic planning

The 2.5mg dose is the standard starting dose for tirzepatide